A 2026 animal study found that combining fucoidan (an extract from brown seaweed) with the cholesterol drug simvastatin reduced dangerous artery plaque by 86% and decreased blood triglycerides by 89%, while also improving the diversity of beneficial gut bacteria. According to Gram Research analysis, this combination worked significantly better than either treatment alone, suggesting that natural compounds may enhance heart disease medications through improvements in digestive health.
Researchers tested a natural extract from seaweed called fucoidan on rabbits with heart disease to see if it could reduce dangerous plaque buildup in arteries. When combined with the common cholesterol drug simvastatin, the seaweed extract dramatically reduced plaque formation and improved the balance of helpful bacteria in the digestive system. According to Gram Research analysis, this combination approach worked better than either treatment alone, suggesting that natural compounds might enhance how traditional heart disease medications work by improving gut health.
Key Statistics
A 2026 animal study published in Frontiers in Microbiology found that combining fucoidan from brown seaweed with simvastatin reduced plaque formation in the abdominal aorta from 41.77% to 5.91%—an 86% reduction—in rabbits with atherosclerosis.
The combination treatment decreased blood triglycerides from 7.75 mmol/L to 0.83 mmol/L (an 89% reduction) and total cholesterol from 24.55 to 17.45 mmol/L (a 29% reduction) in the same 2026 animal study of 24 rabbits.
Research reviewed by Gram found that both fucoidan alone and the fucoidan-simvastatin combination significantly increased the diversity and number of beneficial bacterial species in the digestive system, with the combination treatment modulating 128 different metabolites.
In the 2026 study, seaweed extract combined with cholesterol medication reduced plaque in the thoracic aorta from 10.72% to 2.29%, a 79% reduction, demonstrating particularly strong effects in the upper chest artery.
The Quick Take
- What they studied: Whether a natural extract from brown seaweed (fucoidan) could reduce heart disease and plaque buildup in arteries, especially when combined with a common cholesterol medication
- Who participated: New Zealand rabbits (24 total, divided into groups of 6) that were given a high-fat diet to develop heart disease similar to humans
- Key finding: The combination of seaweed extract and cholesterol medicine reduced dangerous plaque in the main artery by 86% (from 41.77% down to 5.91%) compared to untreated disease, and improved the diversity of healthy gut bacteria
- What it means for you: This research suggests that natural compounds from seaweed might help cholesterol medications work better by improving gut health, though human studies are still needed to confirm these benefits
The Research Details
Scientists created heart disease in rabbits by feeding them a high-fat diet and injuring their arteries with a small balloon. They then divided the sick rabbits into groups: some received seaweed extract alone, some received the extract plus cholesterol medicine, and some received no treatment. The researchers measured how much plaque built up in the arteries, checked blood cholesterol levels, and analyzed the bacteria living in the rabbits’ digestive systems using advanced genetic testing.
This type of study is called a preclinical animal model study. Researchers use it to test new treatments before trying them in humans because rabbit arteries respond to disease in ways very similar to human arteries. The study lasted long enough to see significant changes in plaque formation and bacterial communities.
The researchers used multiple advanced techniques to measure results, including staining artery tissue to see plaque, measuring blood cholesterol with standard lab tests, and using sophisticated genetic analysis to identify which bacteria were present and how they changed with treatment.
This research approach is important because it shows not just whether a treatment works, but also how it works. By measuring both the physical changes in arteries and the changes in gut bacteria, the researchers discovered a new mechanism: the seaweed extract may fight heart disease partly by improving digestive health. This ‘gut-heart connection’ is an emerging area of medical science that could lead to better treatments.
This study was published in Frontiers in Microbiology, a peer-reviewed scientific journal. The researchers used well-established methods for creating heart disease in animals and measuring results. The sample size (6 rabbits per group) is typical for animal studies but relatively small, so results need confirmation in larger studies and eventually in humans. The study was well-designed with clear control groups and multiple measurement methods, which strengthens confidence in the findings.
What the Results Show
The combination treatment was remarkably effective at reducing plaque buildup. In the abdominal aorta (the main artery in the belly), plaque coverage dropped from 41.77% in untreated disease to just 5.91% with combination treatment—an 86% reduction. In the thoracic aorta (the main artery in the chest), plaque fell from 10.72% to 2.29%, a 79% reduction. The seaweed extract alone also helped, but not as dramatically as the combination.
Blood cholesterol levels improved significantly with combination treatment. Total cholesterol dropped from 24.55 to 17.45 mmol/L (a 29% decrease), and triglycerides (another type of blood fat) plummeted from 7.75 to 0.83 mmol/L (an 89% decrease). These improvements in blood chemistry are important because high cholesterol and triglycerides are major risk factors for heart disease.
The treatments also changed the bacteria living in the rabbits’ digestive systems in beneficial ways. Both the seaweed extract alone and the combination treatment increased the diversity and number of different bacterial species. The researchers identified that the treatments changed the activity of 83 to 128 different metabolites (chemical compounds produced by bacteria), suggesting that the gut bacteria were functioning differently in ways that might protect heart health.
The research suggests that the combination therapy may reduce some side effects associated with simvastatin (the cholesterol drug), though the researchers note this needs more investigation. The metabolic changes in the gut bacteria appeared to affect multiple biological pathways related to inflammation and immune function, indicating that the benefits go beyond simple cholesterol reduction. The increased bacterial diversity is particularly important because a more diverse microbiota is generally associated with better overall health.
Previous research had shown that fucoidan (the seaweed extract) has anti-inflammatory and cholesterol-lowering properties, but this is one of the first studies to show how it works through the gut-bacteria connection. The finding that combining a natural compound with a pharmaceutical drug produces better results than either alone is consistent with emerging research on combination therapies. This study adds important evidence that natural compounds shouldn’t be viewed as replacements for proven medications, but rather as potential partners that might enhance their effectiveness.
This study was conducted in rabbits, not humans, so results may not directly apply to people. The sample size was small (6 rabbits per group), which means results need confirmation in larger studies. The study didn’t measure how long the benefits lasted after treatment stopped. The researchers couldn’t definitively prove that the gut bacteria changes caused the heart disease improvements—only that they occurred together. Finally, the study didn’t test different doses of the seaweed extract or investigate which specific components of the seaweed were responsible for the benefits.
The Bottom Line
Based on this research, the combination of fucoidan and simvastatin shows strong promise for treating atherosclerosis in animal models (confidence level: moderate for animal studies). However, human clinical trials are needed before this combination can be recommended as a treatment. People currently taking cholesterol medications should continue following their doctor’s advice and not self-treat with seaweed supplements without medical guidance.
This research is most relevant to people with heart disease or high cholesterol, cardiologists and heart disease researchers, and companies developing natural health products. It’s less immediately relevant to people without heart disease risk factors, though the findings about gut health and disease prevention may have broader applications. Anyone considering adding seaweed supplements to their diet should consult their doctor first, especially if taking cholesterol medications.
In the rabbit study, significant improvements in plaque formation and blood cholesterol were observed over the treatment period. If similar treatments were tested in humans, it would likely take several months to see measurable changes in cholesterol levels and potentially years to see reductions in plaque buildup. Benefits to gut bacteria diversity might appear within weeks to months.
Frequently Asked Questions
Can seaweed supplements help lower cholesterol and prevent heart disease?
Animal research shows fucoidan from brown seaweed combined with cholesterol medication significantly reduces plaque and improves blood lipids, but human studies are needed. Always consult your doctor before adding supplements to heart disease treatment, as they may interact with medications.
How does gut bacteria relate to heart disease and cholesterol?
Emerging research shows gut bacteria produce compounds that affect inflammation, cholesterol levels, and artery health. This 2026 study found that treatments improving bacterial diversity also reduced heart disease, suggesting the gut-heart connection is real and important for cardiovascular health.
Is fucoidan safe to take with simvastatin or other cholesterol drugs?
This animal study suggests the combination is safe and may even reduce certain side effects, but human safety data is limited. Anyone taking cholesterol medications should discuss adding any supplements with their doctor first to check for interactions.
What foods contain fucoidan naturally?
Fucoidan is found in brown seaweed varieties including kelp, wakame, and bladderwrack. These are commonly used in Asian cuisines and available as supplements, though the fucoidan doses in food are typically lower than research doses.
When will this seaweed treatment be available for humans?
This is early-stage animal research. Human clinical trials would need to be conducted first, which typically takes 3-7 years. Fucoidan supplements are already available commercially, but evidence for heart disease treatment in humans remains limited.
Want to Apply This Research?
- Track weekly blood cholesterol levels (if available through home testing) and daily digestive health markers like bowel regularity and bloating to monitor how dietary changes affect both heart and gut health
- Add a daily reminder to log servings of seaweed-containing foods or supplements (if approved by your doctor), paired with your cholesterol medication timing, to build a consistent routine and monitor adherence
- Create a monthly dashboard showing trends in cholesterol readings, digestive symptoms, and energy levels to identify patterns between gut health improvements and overall cardiovascular wellness over 3-6 month periods
This research was conducted in animals (rabbits) and has not yet been tested in humans. The findings are promising but preliminary. Anyone with heart disease, high cholesterol, or taking cholesterol medications should not change their treatment based on this study without consulting their doctor. Seaweed supplements may interact with medications or cause side effects in some people. This article is for educational purposes and should not be considered medical advice. Always consult a healthcare provider before starting new supplements or changing heart disease treatment.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.